Target of rapamycin (TOR) inhibition in renal transplantation: Clinical uses in various populations - Introduction

American Journal of Kidney Diseases

Volumn 38, Issue 4 SUPPL. 2, 2001, Pages

  Hricik, Donald E ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; TARGET OF RAPAMYCIN INHIBITOR; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG WITHDRAWAL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; NEPHROTOXICITY;

EID: 0034804948     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.27503     Document Type: Conference Paper

References (2)

1. Immunosuppressive strategies in transplantation
2. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients